| | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H17N3O |
| Molar mass | 255.321 g·mol−1 |
| 3D model (JSmol) | |
| |
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant. [1] It is structurally and pharmacologically related to pirlindole.
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| Tryptamines |
|
|---|---|
| N-Acetyltryptamines |
|
| α-Alkyltryptamines |
|
| Triptans | |
| Cyclized tryptamines |
|
| Isotryptamines | |
| Related compounds |
|
| | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |